Courses

Cystic fibrosis

Target audience

Paediatric and adult pulmonologists
CF nurses
Physiotherapists
Microbiologists

Educational aims

Following this course, participants will be able to:

Understand the importance of a team approach in the management of CF.
Understand key factors for the organisation of CF care.
Understand key issues related to CF care (epidemiology, CF-diagnosis, pathophysiology of CF lung disease, treatment, psychological issues).

Download all media

Pathophysiology of CF and CFTR directed therapies F. Ratjen (Toronto, Canada)
Management of the newborn screened CF infant I. Balfour-Lynn (London, United Kingdom)
Management of the CF lung pathogens S. Elborn (Belfast, United Kingdom)
Mucolytics and anti-inflammatory lung treatments F. Ratjen (Toronto, Canada)
Practical treatment of CF lung disease C. Haworth (Cambridge, United Kingdom), P. Drevinek (Prague, Czech Republic)
Monitoring of CF lung disease F. Ratjen (Toronto, Canada), I. Balfour-Lynn (London, United Kingdom)
Difficult diagnosis of CF in the context of NBS: CFSPID A. Munck (Paris, France), M. Macek (Prague, Czech Republic)
Difficult diagnosis of CF: CFTR-RD S. Elborn (Belfast, United Kingdom), C. Castellani (Verona, Italy)
Pancreatic, gastrointestinal and liver disease A. Munck (Paris, France)
Physiotherapy: airway clearance L. van der Giessen (Rotterdam, Netherlands)
Nutritional management in childhood A. Munck (Paris, France)
Nutritional management in adults A. Morton (Leeds, United Kingdom)
CF centre care-paediatrics I. Balfour-Lynn (London, United Kingdom), P. Pohunek (Prague, Czech Republic)
CF centre care-adults C. Haworth (Cambridge, United Kingdom), L. Fila (Prague, Czech Republic)
Organisation of CF care question and answer session S. Madge (London, United Kingdom)
Physiotherapy: inhalation, exercise, urinary incontinence, spinal evaluation – L. van der Giessen, L. Smolikova L. van der Giessen (Rotterdam, Netherlands), L. Smolikova (Prague, Czech Republic)
The microbiology lab P. Drevinek (Prague, Czech Republic)
CF related diabetes A. Morton (Leeds, United Kingdom)
CF related bone disease C. Haworth (Cambridge, United Kingdom)
Treatment of advanced CF lung disease and end of life care L. Dupont (Leuven, Belgium)
Adherence and psychological aspects of CF T. Havermans (Leuven, Belgium)
Nontuberculous mycobacterial disease in CF C. Haworth (Cambridge, United Kingdom)
Transition S. Madge (London, United Kingdom)
Lung transplantation L. Dupont (Leuven, Belgium)